Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
for
Erectile Dysfunction Due to Arterial Insufficiency,
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: Male
Age: 40+
Code: NCT05868668
Recruiting
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
for
Cirrhosis, Liver
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18 - 70
Code: NCT03208868
Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Columbus OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase3, Recruiting
Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
for
Alcoholic Liver Disease, COVID 19 Pneumonia
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 21+
Code: NCT04858412
Recruiting
Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths Versus Conventional Sheaths for Treatment of Nephrolithiasis
for
Kidney Stone
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT05993546
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
REMASTer: REcurrent Brain Metastases After SRS Trial
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Cleveland OH, Troy MI, Springfield OH, Midland MI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06585410
Phase3, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue